meet our
Managing Directors

Ross began his entrepreneurial journey as CEO of 2e Group, a privately-owned omnichannel pharma/biotech commercialization agency that he scaled into one of North America’s largest independent firms as well as received the “Healthcare Agency of the Year” award for three consecutive years. Ross also spearheaded strategic acquisitions and market expansions, positioning the business as a dominant industry force and securing an elite roster of Fortune 100 clients.

In 2019, Ross led the successful sale of 2e Group to PE-backed medical communications leader Fishawack Health (now Avalere Health). Post-acquisition, he was appointed Chief Commercial Officer, overseeing corporate business development and M&A. During his tenure, Ross pioneered the now-ubiquitous concept of fully integrated pharma commercialization, helping drive the company’s growth to over $1.1 billion in enterprise value.

Following his success in corporate M&A, Ross founded EONOVA, an exit planning and advisory firm. Through EONOVA, he leverages his deep expertise in entrepreneurial leadership, strategic growth, and both buy- and sell-side M&A to help business owners identify valuation gaps, plan successful exits, and accelerate enterprise value.

In addition to founding EONOVA, Ross is a sought-after strategic growth consultant, particularly for businesses in healthtech, pharma/biotech, and professional services. He is frequently engaged by PE and VC investors to evaluate acquisition targets, conduct commercial due diligence, and develop post-close growth strategies.

Ross is a Certified Exit Planning Advisor (CEPA) with the Exit Planning Institute, an Agency Council Member of Forbes, and Mid-Americas U.S. Regional Board Chairman-Elect for the Young Presidents’ Organization (YPO). He is also the founder of TEDx ThinkWell and TechStars Startup Weekend HealthBio, and Silver Entrepreneur of the Year for Medical Marketing & Media.

He holds a Bachelor of Science in Advertising & Journalism from Texas A&M University.